- Home
- JANX vs CNNE Comparison
JANX vs CNNE Comparison
Compare JANX & CNNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | JANX | CNNE |
|---|---|---|
| Founded | 2017 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Restaurants |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 890.8M | 822.0M |
| IPO Year | 2021 | N/A |
Fundamental Metrics
Financial Performance| Metric | JANX | CNNE |
|---|---|---|
| Price | $13.29 | $14.26 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $57.36 | $22.25 |
| AVG Volume (30 Days) | ★ 1.7M | 458.1K |
| Earning Date | 02-26-2026 | 02-23-2026 |
| Dividend Yield | N/A | ★ 4.21% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $10,000,000.00 | ★ $430,200,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $12.12 | $13.83 |
| 52 Week High | $44.83 | $21.96 |
Technical Indicators
Market Signals| Indicator | JANX | CNNE |
|---|---|---|
| Relative Strength Index (RSI) | 36.48 | 38.26 |
| Support Level | $12.12 | $14.12 |
| Resistance Level | $14.16 | $14.77 |
| Average True Range (ATR) | 0.75 | 0.42 |
| MACD | 0.04 | -0.07 |
| Stochastic Oscillator | 17.66 | 25.57 |
Price Performance
Historical ComparisonAbout JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About CNNE Cannae Holdings Inc.
Cannae Holdings Inc is a holding company that manages and operates a group of companies and investments. The company's reportable segments are Restaurant Group, Dun & Bradstreet, Alight, BKFC, Corporate and Other. Majority of the company's revenue is generated from its Restaurant Group segment which represents the operations of O'Charley's and Ninety Nine Restaurants.